NCT04842448 - Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

September 27, 2023

Study Completion Date

June 17, 2024

Conditions

COVID-19Post COVID-19 ConditionPost COVID-19 Condition, UnspecifiedPost COVID ConditionPost-COVID SyndromePost-Acute COVID-19 Syndrome

Interventions

DRUG

Hyperbaric oxygen

Hyperbaric oxygen 240 kPa for 90 minutes (with 10 min compression time, 2 air bakes and 10 minutes decompression time).

PROCEDURE

Sham treatment

Sham treatment 134-120 kPa Air (with 5 min compression time, and 5 min decompression to 120 kPa, two air brakes will be reported to the subjects)

Trial Locations (1)

Karolinska University Hospital, Stockholm

All Listed Sponsors

collaborator

Karolinska Institutet

OTHER

collaborator

Karolinska Trial Alliance

INDUSTRY

collaborator

EDC Scandinavia AB

UNKNOWN

collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

Region Stockholm

OTHER_GOV

collaborator

The Swedish Research Council

OTHER_GOV

lead

Karolinska University Hospital

OTHER